Figure 3: Inhibition of ATPase activity of WT VCP/p97 and the two D1 and D2 mutants by the three repositioned drugs in this study.
From: A structure- and chemical genomics-based approach for repositioning of drugs against VCP/p97 ATPase
DBeQ and NMS-873 were used as positive controls.
